• Issue

    Inflammatory Bowel Diseases: Volume 16, Issue 9

    1447-1630
    September 2010
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Letters to the Editor

Activated factor XI and tissue factor in inflammatory bowel disease

A. Undas MD, PhD,  D. Owczarek MD,  M. Gissel BS,  K. Salapa MA,  K.G. Mann PhD,  S. Butenas PhD, 
  • Pages: 1447-1448
  • First Published: 20 August 2010

Response to Baumgart review

Brian G. Feagan MD,  Asit Parikh MD, PhD, 
  • Page: 1449
  • First Published: 20 August 2010

Lewis and Sumner syndrome following infliximab treatment in Crohn's disease: A report of 2 cases

Stephane Nancey MD, PhD,  Françoise Bouhour MD,  Gilles Boschetti MD,  Christophe Magnier MD,  Pierre-Marie Gonneau MD, PhD,  Jean-Christophe Souquet MD, PhD,  Dominique Kaiserlian PhD,  Bernard Flourie MD, PhD, 
  • Pages: 1450-1453
  • First Published: 20 August 2010

Treatment-associated acute myeloid leukemia in a patient with Crohn's disease on 6-mercaptopurine

Koushik K. Das MD,  Ha Thanh Nishino MD,  Andrew T. Chan MD, MPH, 
  • Pages: 1454-1456
  • First Published: 20 August 2010

Low-dose naltrexone for treatment of duodenal Crohn's disease in a pediatric patient

Angela Shannon MD,  Naim Alkhouri MD,  Shadi Mayacy MD,  Barbara Kaplan MD,  Lori Mahajan MD, 
  • Page: 1457
  • First Published: 20 August 2010

Original Basic Science Articles

Detection of intestinal inflammation by MicroPET imaging using a 64Cu-labeled anti-β7 integrin antibody

Jason L.J. Dearling PhD,  Eun Jeong Park PhD,  Patricia Dunning BS,  Amanda Baker BS,  Frederic Fahey DSc,  S.Ted Treves MD,  Sulpicio G. Soriano MD,  Motomu Shimaoka MD, PhD,  Alan B. Packard PhD,  Dan Peer PhD, 
  • Pages: 1458-1466
  • First Published: 20 August 2010

Impaired erythrocyte antioxidant defense in active inflammatory bowel disease: Impact of anemia and treatment

Malgorzata Krzystek-Korpacka PhD,  Katarzyna Neubauer MD, PhD,  Izabela Berdowska PhD,  Bogdan Zielinski PhD,  Leszek Paradowski MD, PhD,  Andrzej Gamian PhD, 
  • Pages: 1467-1475
  • First Published: 20 August 2010

Overexpression of translocator protein in inflammatory bowel disease: Potential diagnostic and treatment value

Mariano A. Ostuni PhD,  Leeyah Issop MSc,  Gabriel Péranzi PhD,  Francine Walker MD, PhD,  Magali Fasseu BSc,  Carole Elbim MD, PhD,  Vassilios Papadopoulos DPharm, PhD,  Jean-Jacques Lacapere PhD, 
  • Pages: 1476-1487
  • First Published: 20 August 2010

Expression of the antimicrobial peptide α-defensin/cryptdins in intestinal crypts decreases at the initial phase of intestinal inflammation in a model of inflammatory bowel disease, IL-10-deficient mice

Yuhei Inaba MD, PhD,  Toshifumi Ashida MD, PhD,  Takahiro Ito MD, PhD,  Chisato Ishikawa MD, PhD,  Hiroki Tanabe MD, PhD,  Atsuo Maemoto MD, PhD,  Jiro Watari MD, PhD,  Tokiyoshi Ayabe MD, PhD,  Yusuke Mizukami MD, PhD,  Mikihiro Fujiya MD, PhD,  Yutaka Kohgo MD, PhD, 
  • Pages: 1488-1495
  • First Published: 20 August 2010

CCL2 (pM levels) as a therapeutic agent in inflammatory bowel disease models in mice†

N. Maharshak MD,  G. Hart PhD,  E. Ron MSc,  E. Zelman MSc,  A. Sagiv MSc,  N. Arber MD, PhD,  E. Brazowski MD,  R. Margalit,  E. Elinav MD, PhD,  I. Shachar PhD, 
  • Pages: 1496-1504
  • First Published: 20 August 2010

Prostaglandin E2 inhibits migration of colonic lamina propria fibroblasts

Florian Rieder MD,  Martina Georgieva MD,  Anja Schirbel MD,  Monika Artinger,  Anita Zügner,  Martin Blank MD,  Julia Brenmoehl PhD,  Jürgen Schölmerich MD,  Gerhard Rogler MD, PhD, 
  • Pages: 1505-1513
  • First Published: 20 August 2010

Bifidobacterium lactis inhibits NF-κB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice†‡

Seung Won Kim MS,  Hee Man Kim MD,  Kyoung Min Yang PhD,  Sun-Ah Kim BS,  Sung-Kyu Kim BS,  Min Ji An MS,  Jae Jun Park MD,  Sang Kil Lee MD, PhD,  Tae Il Kim MD, PhD,  Won Ho Kim MD, PhD,  Jae Hee Cheon MD, PhD, 
  • Pages: 1514-1525
  • First Published: 20 August 2010

Original Clinical Articles

Evaluation of endoscopic and imaging modalities in the diagnosis of structural disorders of the ileal pouch

Linda Tang MD,  Hui Cai PhD,  Lauren Moore BS,  Bo Shen MD, 
  • Pages: 1526-1531
  • First Published: 20 August 2010

Simple score to identify colectomy risk in ulcerative colitis hospitalizations

Ashwin N. Ananthakrishnan MD, MPH,  Emily L. McGinley MS, MPH,  David G. Binion MD,  Kia Saeian MD, MSc, Epi, 
  • Pages: 1532-1540
  • First Published: 20 August 2010

Thiopurine therapy in inflammatory bowel disease patients: Analyses of two 8-year intercept cohorts†

B. Jharap MD,  M.L. Seinen MS,  N.K.H. de Boer MD, PhD,  J.R. van Ginkel PhD,  R.K. Linskens MD, PhD,  J.C. Kneppelhout MD,  C.J.J. Mulder MD, PhD,  A.A. van Bodegraven MD, PhD, 
  • Pages: 1541-1549
  • First Published: 20 August 2010

High incidence of inflammatory bowel disease in Australia: A prospective population-based Australian incidence study

Jarrad Wilson FRACP,  Christopher Hair FRACP,  Ross Knight FRACP,  Anthony Catto-Smith MD,  Sally Bell MD,  Michael Kamm MD,  Paul Desmond FRACP,  John McNeil PhD,  William Connell MD, 
  • Pages: 1550-1556
  • First Published: 20 August 2010

Increased expression and cellular localization of spermine oxidase in ulcerative colitis and relationship to disease activity

Shih-Kuang S. Hong MD,  Rupesh Chaturvedi PhD,  M. Blanca Piazuelo MD,  Lori A. Coburn MD,  Christopher S. Williams MD, PhD,  Alberto G. Delgado HTL,  Robert A. Casero Jr PhD,  David A. Schwartz MD,  Keith T. Wilson MD, 
  • Pages: 1557-1566
  • First Published: 20 August 2010
Open Access

Direct comparison of two different mesalamine formulations for the induction of remission in patients with ulcerative colitis: A double-blind, randomized study†

Hiroaki Ito MD,  Mitsuo Iida MD,  Takayuki Matsumoto MD,  Yasuo Suzuki MD,  Hidetaka Sasaki PhD,  Toyomitsu Yoshida BSc,  Yuichi Takano BSc,  Toshifumi Hibi MD, 
  • Pages: 1567-1574
  • First Published: 20 August 2010
Open Access

Direct comparison of two different mesalamine formulations for the maintenance of remission in patients with ulcerative colitis: A double-blind, randomized study†

Hiroaki Ito MD,  Mitsuo Iida MD,  Takayuki Matsumoto MD,  Yasuo Suzuki MD,  Yoshiyuki Aida MSc,  Toyomitsu Yoshida BSc,  Yuichi Takano BSc,  Toshifumi Hibi MD, 
  • Pages: 1575-1582
  • First Published: 20 August 2010

Basic Science Review

Toll-like receptors in inflammatory bowel diseases: A decade later

Elke Cario MD, 
  • Pages: 1583-1597
  • First Published: 20 August 2010

Clinical Reviews

Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease

Udayakumar Navaneethan MD,  Bo Shen MD, 
  • Pages: 1598-1619
  • First Published: 20 August 2010

Review Articles

Cytomegalovirus in inflammatory bowel disease: Pathogen or innocent bystander?

Garrett Lawlor MD,  Alan C. Moss MD, 
  • Pages: 1620-1627
  • First Published: 20 August 2010

Clinical Viewpoint

Mucosal healing as an index of colitis activity: Back to histological healing for future indices

Burton I. Korelitz MD, 
  • Pages: 1628-1630
  • First Published: 20 August 2010